MAVYRET
AbbVie Inc.
Mark For: MAVYRET® trademark registration is intended to cover the categories of
| Research |
OneLook
Acronym Finder
|
| Serial Number | 87375678 |
| Registration Number | 5361413 |
| Mark Literal Elements | MAVYRET |
| Mark Drawing Type | 4 - STANDARD CHARACTER MARK |
| Mark Type | Trademark |
| Current Location | PUBLICATION AND ISSUE SECTION 2017-11-16 |
| Basis | 1(a) |
| Class Status | ACTIVE |
| Primary US Classes |
|
| Primary International Class |
|
| Filed Use | No |
| Current Use | Yes |
| Intent To Use | No |
| Filed ITU | Yes |
| 44D Filed | No |
| 44E Current | No |
| 66A Current | No |
| Current Basis | No |
| No Basis | No |
| Attorney Name | Cheryl A. Withycombe |
| Attorney Docket Number | ABVT68954 |
| Law Office Assigned | N30 |
| Employee Name | MAYER, DAVID COREY |
Timeline
| 2017-03-17 | Application Filed |
| 2017-07-11 | Published |
| 2017-07-11 | Published for Opposition |
| 2017-08-03 | Date of First Use |
| 2017-08-03 | Date of Use In Commerce |
| 2017-11-16 | Location: PUBLICATION AND ISSUE SECTION |
| 2017-12-19 | Status: Live/Registered |
| 2017-12-19 | Status: Registered. The registration date is used to determine when post-registration maintenance documents are due. |
| 2017-12-19 | Trademark Registered |
| 2018-07-08 | Transaction Date |
| 2024-06-19 | Maintenance Late Fee Date |
Trademark Parties (Applicants & Owners)
| Party: |  AbbVie Inc. |
| Address | 1 N. Waukegan Road 1 N. Waukegan Road North Chicago, ILLINOIS UNITED STATES 60064 |
| Legal Entity Type | Corporation |
| Legal Entity State | DELAWARE |
Documents
 Drawing | 2017-03-17 | |
| TEAS RF New Application | 2017-03-17 | |
| Notation to File | 2017-06-01 | |
| XSearch Search Summary | 2017-06-01 | |
| TRAM Snapshot of App at Pub for Oppostn | 2017-06-05 | |
| Notice of Publication | 2017-06-21 | |
| Notification Of Notice of Publication | 2017-06-21 | |
| OG Publication Confirmation | 2017-07-11 | |
| Notice of Allowance | 2017-09-05 | |
| Specimen | 2017-10-20 | |
| Statement of Use | 2017-10-20 | |
| ITU Unit Action | 2017-11-07 | |
| Notice of Acceptance of Statement of Use | 2017-11-17 | |
| TRAM Snapshot of App at Pub for Oppostn | 2017-11-17 | |
| Registration Certificate | 2017-12-19 | |
| Courtesy E-Reminder of Sec. 8 (6-yr) | 2022-12-19 | |
| Section 8 and 15 | 2023-10-31 | |
| Specimen | 2023-10-31 |
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders |
Trademark Filing History
| Description | Date | Proceeding Number |
|---|---|---|
| TEAS SECTION 8 & 15 RECEIVED | 2023-10-31 | |
| COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | 2022-12-19 | |
| REGISTERED-PRINCIPAL REGISTER | 2017-12-19 | |
| NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | 2017-11-17 | |
| ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | 2017-11-16 | |
| STATEMENT OF USE PROCESSING COMPLETE | 2017-11-06 | |
| CASE ASSIGNED TO INTENT TO USE PARALEGAL | 2017-11-06 | |
| USE AMENDMENT FILED | 2017-10-20 | |
| TEAS STATEMENT OF USE RECEIVED | 2017-10-20 | |
| NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2017-09-05 | |
| PUBLISHED FOR OPPOSITION | 2017-07-11 | |
| OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2017-07-11 | |
| NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2017-06-21 | |
| APPROVED FOR PUB - PRINCIPAL REGISTER | 2017-06-02 | |
| ASSIGNED TO EXAMINER | 2017-06-01 | |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | 2017-03-23 | |
| NEW APPLICATION ENTERED | 2017-03-21 |
Similar Marks
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 MAVYRET 88488568 not registered Live/Pending |
AbbVie Inc. 2019-06-25 |
 MAVYRET 87375678 5361413 Live/Registered |
AbbVie Inc. 2017-03-17 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 